Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Radiofrequency Ablation Devices Companies

Radiofrequency ablation (RFA) devices are used in medical procedures to treat various conditions by using thermal energy to destroy or ablate targeted tissues. These devices are commonly used in the treatment of tumors, cardiac arrhythmias, and chronic pain.

Latest Radiofrequency Ablation Devices Companies Update

July 2023: The initial case of Broncus Holding Corporation's targeted lung denervation (TLD) radiofrequency ablation system, designed to treat chronic obstructive pulmonary disease (COPD), has been successfully completed. The evaluation of the TLD ablation system's safety and efficacy will be the subject of a multicenter study conducted at 26 sites throughout China. The initial surgical procedure was carried out at the West China Hospital affiliated with Sichuan University in China. Globally, COPD ranks as the third most prevalent cause of mortality and is distinguished by persistent coughing and respiratory distress. It is frequently brought on by air pollution and smoking. COPD is an intractable disease, per the World Health Organization (WHO), but surgical intervention is a viable symptomatic treatment option.

March 2023: The Department of Physical Medicine and Rehabilitation at the University of Utah and Stratus Medical, a company dedicated to advancing radiofrequency (RF) ablation treatment for pain, announced today the enrollment of the first patient in the COBRA study. This study is a double-blind, randomized trial that compares bipolar treatment with Nimbus® RF Multitined Expandable Electrode to conventional radiofrequency ablation for the treatment of sacroiliac joint (SIJ) pain. At three-month, six-month, twelve-month, eighteen-month, and twenty-four-month endpoints, this IRB-approved study will be the first level I, double-blind, randomized control trial to compare Nimbus bipolar radiofrequency ablation to conventional radiofrequency ablation. Quantifying the efficacy and duration of relief for the well-known bipolar application in the sacroiliac joint is the objective of this research.

List of Radiofrequency Ablation Devices Key companies in the market

Boston scientific corporation

Medtronic Inc

Stryker

Cosman Medical, Inc.

St. Jude Medical

Smith & Nephew

Johnson & Johnson (J&J) Services, LLC

Angiodynamics

RF Medical Co, Ltd

AtriCure

Radiofrequency Ablation Devices Market Highlights:

Radiofrequency Ablation Devices Market Size

Radiofrequency Ablation Devices Market Trends

Radiofrequency Ablation Devices Market Analysis

Radiofrequency Ablation Devices Market Share

Radiofrequency Ablation Devices Market Highlights:

Radiofrequency Ablation Devices Market Trends

Radiofrequency Ablation Devices Market Analysis

Radiofrequency Ablation Devices Market Share

Radiofrequency Ablation Devices Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.